Effects of phenobarbital on stereoselective metabolism of ifosfamide in rats

Drug Metabolism and Disposition

Volumn 26, Issue 5, 1998, Pages 476-482

  Lu, Hong ^b   Wang, Jeff J ^b   Chan, Kenneth K ^a   Young, Donn ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IFOSFAMIDE; PHENOBARBITAL;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CONFORMATION; DRUG DEGRADATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG HYDROXYLATION; DRUG URINE LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOCHEMISTRY;

ANIMALS; ANTICONVULSANTS; ANTINEOPLASTIC AGENTS, ALKYLATING; IFOSFAMIDE; MALE; METABOLIC CLEARANCE RATE; PHENOBARBITAL; RATS; RATS, SPRAGUE-DAWLEY; STEREOISOMERISM;

ANIMALIA;

EID: 0031902932     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Barry M and Feely J (1990) Enzyme induction and inhibition. Pharmacol Ther 48:71-94.
2. Boss J, Welslau U, Ritter J, Blaschke G and Schellong G (1991) Urinary excretion of the enantiomers of ifosfamide and its inactive metabolite in children. Cancer Chemother Pharmacol 28:455-460.
3. Chan KK (1982) A simple integrated method for drug and derived metabolite kinetics: an application of the statistical moment theory. Drug Merab Dispos 10:474-479.
4. Chang TKH, Weber GF, Crespi CL and Waxman DJ (1993) Differential activation of cyclophosphamide and ifosfamide by cytochromes P-450 2B and 3A in human liver microsomes. Cancer Res 53:5629-5637.
5. Corlett SA and Chrystyn H (1994) Enantiomeric separation of R-and S-ifosfamide and their determination in serum from clinical subjects. J Chromatogr 654:152-158.
6. Cox PJ, Farmer PB, Jarman M, Kinas RW and Stec WJ (1978) Stereoselectivity in the metabolism of the enantiomers of cyclophosphamide in mice, rats, and rabbits. Drug Metab Dispos 6:617-622.
7. Dollery SC (1991a) Cyclophosphamide, in Therapeutic Drugs (Dollery SC ed) pp C366-C372, Churchill Livingstone, Edinburgh.
8. Dollery SC (1991b) Ifosfamide, in Therapeutic Drugs (Dollery SC ed) pp 110-115, Churchill Livingstone, Edinburgh.
9. Farmer PB (1988) Enantiomers of cyclophosphamide and iphosphamide. Biochem Pharmacol 37:145-148.
10. Gal J, Wright J and Cho AK (1976) In vitro metabolism of amphetamine: an apparent enantiomeric interaction. Res Commun Chem Pathol Pharmacol 15:525-540.
11. Giacomini KM, Nelson WL, Pershe RA, Valdivieso L, Tumer-Tamiyasu K and Blaschke F (1986) In vivo interaction of enantiomers of disopyramide in human subjects. J Pnarmacokinet Biopharm 14:335-356.
12. Goren MP, Wright RK, Pratt CB and Pell PE (1986) Dechloroethylation of ifosfamide and neurotoxicity. Lancet 2:1219-1220.
13. Granvil CP, Gehrcke B, Konig WA and Wainer FW (1993) Determination of the enantiomers of ifosfamide and its 2-and 3-N-dechloroethylated metabolites in plasma and urine using enantioselective gas chromatography with mass spectrometric detection. J Chromatogr 622: 21-31.
14. Granvil CP, Sharkawi M, Ducharme J, Madan A, Sanzghiri U, Parkinson A and Wainer IW (1996) Roles of CYP2B6 and CYP3A4 in the in vitro N-dechloroethylation of ifosfamide enantiomers by human liver microsomes. Proc Int Soc Study Xenobiotics 10:360.
15. Granvil CP, Wang T, Batist G and Wainer IW (1994) Influence of phenobarbital induction on the enantioselective N-dechloroethylation of ifosfamide enantiomers in the rat. Drug Metab Dispos 22:165-167.
16. Hong PS and Chan KK (1987) Identification and quantitation of alcophosphamide, a metabolite of cyclophosphamide, in the rat using chemical ionization mass spectrometry. Biomed Mass Spectrom 14:167-172.
17. Kroemer NK, Fischer C, Meese CO and Eichelbaum M (1991) Enantiomer/enantiomer interaction of (S)-and (R)-propafenone for cytochrome P450IID6-catalyzed 5-hydroxylation: in vitro evaluation of the mechanism. Mol Pharmacol 40:135-142.
18. Kupfer A, Desmond PV, Schenker S and Branch RA (1982) Stereoselective metabolism and disposition of the enantiomers of mephenytoin during chronic oral administration of the racemic drug in man. J Pharmacol Exp Ther 221:590-597.
19. Lewis LD and Meanwell CA (1990) Ifosfamide pharmacokinetics and neurotoxicity. Lancet 335:175-176.
20. Masurel D and Wainer IW (1989) Analytical and preparative high-performance liquid chromatographic separation of the enantiomers of ifosfamide, cyclophosphamide and trofosfamide and their determination in plasma. J Chromatogr 490:133-143.
21. Misiura K, Okruszek A, Pankiewick K, Stec WK, Czownicki Z and Utracka B (1983) Stereospecific synthesis of chiral metabolites of ifosfamide and their determination of the urine. J Med Chem 26:674-679.
22. Okey AB (1990) Enzyme induction in the cytochrome P-450 system. Pharmacol Ther 45:241-298.
23. Pang KS and Kwan KC (1983) Methods and assumptions in the kinetic estimation of metabolite formation: a commentary. Drug Metab Dispos 11:79-84.
24. Prasad VK, Corlett SA, Abaasi K, Heney D, Lewis I and Chrystyn H (1994) Ifosfamide enantiomers: pharmacokinetics in children. Cancer Chemother Pharmacol 34:447-449.
25. Ruzicka JA and Ruenitz PC (1992) Cytochrome P-450-mediated N-dechloroethylation of cyclophosphamide and ifosfamide in the rat. Drug Metab Dispos 20:770-772.
26. Wainer IW, Ducharme J, Granvil CP, Trudean M and Leyland-Jones B (1994a) Ifosfamide stereoselective dechloroethylation and neurotoxicity. Lancet 343:982-983.
27. Wainer IW, Granvil CP, Wang T and Batist G (1994b) Efficacy and toxicity of ifosfamide stereoisomers in an in vivo rat mammary carcinoma model. Cancer Res 54:4393-4397.
28. Wainer IW, Stewart CF, Young CL, Masurel D and Frank H (1988) Clinical pharmacokinetics (PK) of the enantiomers of ifosfamide (IFF) in pediatric patients. Proc Am Soc Clin Oncol 7:72.
29. Walker D, Flinois JP, Monkman SC, Beloc C, Boddy AV, Cholerlon S, Daly AK, Lind MJ, Pearson ADJ, Beaune PH and Idle JR (1994) Identification of the major human hepatic cytochrome P430 involved in activation and N-dechloroethylation of ifosfamide. Biochem Pharmacol 47:1157-1163.
30. 3-dechloroethylifosfamide, and iphosphoramide mustard in plasma by gas chromatographic-mass spectrometry. J Chromatogr 674:205-217.
31. Wang JJ-H and Chan KK (1995b) Identification of new metabolites of ifosfamide in rat urine using ion cluster technique. J Mass Spectrom 30:675-683.
32. Wang JJ-H and Chan KK (1996) Stereospecific synthesis of tetradeuterated (R)-and (S)-ifosfamide. J Labelled Compd 38:105-115.
33. Waxman DJ and Azaroff L (1992) Phenobarbital induction of cytochrome P450 gene expression. Biochem J 281:577-592.
34. Weber GF and Waxman DJ (1993) Activation of the anti-cancer drug ifosfamide by rat liver microsomal P450 enzymes. Biochem Pharmacol 45:1685-1694
35. Yu L and Waxman DJ (1996) Role of cytochrome P450 in oxazaphosphorine metabolism: deactivation via N-dechloroethylation and activation via 4-hydroxylation catalyzed by distinct subsets of rat liver cytochrome P450. Drug Metab Dispos 34:1254-1262.
36. Zheng JJ, Chan KK and Muggia F (1994) Preclinical pharmacokinetics and stability of isophosphoramide mustard. Cancer Chemother Pharmacol 33:391-398.